• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dynatronics Corporation filed SEC Form 8-K: Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Leadership Update

    1/12/26 4:15:58 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care
    Get the next $DYNT alert in real time by email
    Dynatronics Corp.: Form 8-K - Filed by newsfilecorp.com

    false 2026-01-09 0000720875 Dynatronics Corp. 0000720875 2026-01-09 2026-01-09

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ___________________________

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): January 9, 2026

    DYNATRONICS CORP.
    (Exact name of registrant as specified in its charter)

    Utah 000-12697 87-0398434
    (State or other jurisdiction (Commission (IRS Employer
    of incorporation) File Number) Identification No.)

    1200 Trapp Rd.
    Eagan, Minnesota, United States 55121
    (Address of principal executive offices) (ZIP Code)

    Registrant’s telephone number, including area code: (801) 568-7000

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐ Pre-commencement communications pursuant to Rule 14(d)-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(g) of the Act:

    Title of each class   Trading Symbols   Name of each exchange on which registered
    Common stock, no par value   DYNT   OTCQB

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


    Item 1.03 Bankruptcy or Receivership.

    On January 9, 2026, after considering all strategic alternatives, Dynatronics Corporation (the "Company"), and its wholly-owned subsidiaries, Hausmann Enterprises, LLC, Bird & Cronin, LLC, and Dynatronics Distribution Company, LLC (collectively, the "Debtors"), each ceased operations and filed a voluntary petition for relief (collectively, the "Bankruptcy Filings") under Chapter 7 of Title 11 of the United States Code, 11 U.S.C. §§ 101 et seq. in the United States Bankruptcy Court (the "Bankruptcy Court") for the District of Minnesota (collectively, the "Bankruptcy Cases").

    As a result of the Bankruptcy Filings, a Chapter 7 trustee will be appointed by the Bankruptcy Court in each of the Bankruptcy Cases and will administer the respective Debtor's bankruptcy estate, including liquidating the assets of each respective Debtor in accordance with the Bankruptcy Code. With respect to each Bankruptcy Case, once a Chapter 7 trustee is appointed, an initial hearing for creditors will be scheduled, and a Notice of Bankruptcy Case Filing for such Bankruptcy Case will be sent to known creditors.

    Item 2.04 Triggering Events that Accelerate or Increase a Direct Financial Obligation or Obligation under an Off-Balance Sheet Arrangement.

    The Bankruptcy Filings triggered events of default under certain of the Debtors' contracts, agreements or debt instruments, which may result in the termination of, or an acceleration of the Debtors' obligations under, such contracts, agreements or debt instruments. Without limiting the foregoing, the Bankruptcy Filings:

    (i) Trigger one or more events of default under the Company's Loan and Security Agreement dated as of August 1, 2023 with Gibraltar Business Capital, LLC. An event of default under the Loan and Security Agreement entitles Gibraltar Business Capital, LLC to enforce the rights and pursue the remedies described in the Loan and Security Agreement, including acceleration of the outstanding indebtedness under the Loan and Security Agreement; and

    (ii) Trigger redemption rights under the (A) Designation of Preferences, Rights and Limitations of the Series A 8% Convertible Preferred Stock of the Company contained in the Company's Amended and Restated Articles of Incorporation, and (B) Certificate of Designations, Preferences and Rights of the Series B Convertible Preferred Stock of the Company.

    Such events of default and redemption rights, however, may be stayed pursuant to 11 U.S.C. § 362.

    Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    In connection with the Bankruptcy Filings, the appointed Chapter 7 trustee(s) will assume control over the assets and liabilities of the Debtors, effectively eliminating the authority and powers of the Board of Directors of the Company and its executive officers to act on behalf of the Company and the other Debtors. Accordingly, effective as of the appointment of the Chapter 7 trustee(s), Brian Baker, Andrew Hulett, R. Scott Ward, Erin S. Enright, and David B. Holtz resigned from their positions as directors of the Company. The resignations are not the result of any disagreement with the Company regarding the Company's operations, policies, or practices. The executive officers of the Company, including the Company's CEO, Brian Baker, ceased to be officers and employees of the Company and each other Debtor, as applicable, effective as of the appointment of the Chapter 7 trustee(s).

    2


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Date: January 9, 2026 DYNATRONICS CORPORATION
         
      By:     /s/ Brian Baker
      Name: Brian Baker
      Title: Authorized Signatory

    3


    Get the next $DYNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DYNT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DYNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Essig Stuart acquired 16,095 shares, increasing direct ownership by 0.30% to 4,533,824 units (SEC Form 4)

    4 - DYNATRONICS CORP (0000720875) (Issuer)

    10/30/25 9:10:45 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Large owner Provco Ventures 1 Lp acquired 8,043 shares, increasing direct ownership by 0.29% to 2,739,998 units (SEC Form 4)

    4 - DYNATRONICS CORP (0000720875) (Issuer)

    10/30/25 9:10:25 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Director Enright Erin S. acquired 16,095 shares (SEC Form 4)

    4 - DYNATRONICS CORP (0000720875) (Issuer)

    10/30/25 8:04:18 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

    Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven

    1/8/24 8:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Appointment of Dr. Christopher von Jako as new CEO

    Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca

    6/21/23 9:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

    Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive

    5/18/23 8:05:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    SEC Filings

    View All

    Dynatronics Corporation filed SEC Form 8-K: Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Leadership Update

    8-K - DYNATRONICS CORP (0000720875) (Filer)

    1/12/26 4:15:58 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - DYNATRONICS CORP (0000720875) (Filer)

    12/17/25 8:10:02 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Dynatronics Corporation

    10-Q - DYNATRONICS CORP (0000720875) (Filer)

    11/19/25 9:36:08 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Leadership Updates

    Live Leadership Updates

    View All

    Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

    Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven

    1/8/24 8:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Appointment of Dr. Christopher von Jako as new CEO

    Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca

    6/21/23 9:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

    Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive

    5/18/23 8:05:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Financials

    Live finance-specific insights

    View All

    Dynatronics Corporation Reports Third Quarter Fiscal Year 2023 Financial Results and Business Highlights

    Eagan, Minnesota--(Newsfile Corp. - May 11, 2023) - Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its third quarter of fiscal year 2023 ended March 31, 2023, and provided an update on the business.CEO Commentary"Dynatronics experienced revenue challenges in our third fiscal quarter as a result of three external factors. As a result, we are adjusting our spending and revenue expectations as we respond to the specific impacts of:Competitive acquisitions by a significant rehabilitation customer; Reduction in specific SKUs of an OEM customer for the

    5/11/23 7:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Corporation Schedules Conference Call to Report Third Quarter Results for Fiscal 2023

    Eagan, Minnesota--(Newsfile Corp. - April 27, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its third quarter of fiscal year 2023 on Thursday, May 11, 2023 before the market opens.The company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session with analysts, at 8:00 AM ET on Thursday, May 11, 2023, to review its third quarter results.Interested persons may access the live conference call by dialing 1-800-319-4610 (U.S./Canada calle

    4/27/23 8:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Corporation Reports Second Quarter Fiscal Year 2023 Financial Results and Business Highlights

    EAGAN, MN / ACCESSWIRE / February 9, 2023 / Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its second quarter of fiscal year 2023 ended December 31, 2022, and provided an update on the business.CEO Commentary"The year-over-year improvement in gross margin of 8.4% or nearly $1.0 million in gross profit was a solid improvement. We are pleased with our progression, but we have more work to do. New, targeted, and innovative, product releases are the third pillar of our gross margin improvement plan, and we plan to continue to improve our performance in

    2/9/23 7:30:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

    SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

    2/14/23 12:35:29 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

    SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

    2/13/23 12:33:51 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

    SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

    1/14/22 12:22:28 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care